Interní Med. 2001; 3(2): 80-81

Problematika hyperprolaktinémie při terapii sulpiridem z pohledu endokrinologa

MUDr. Hana ©arapatková1, MUDr. Yvona Hrčková2, MUDr. Jarmila ©moldasová3
1 Interní a endokrinologická ordinace Olomouc
2 I. interní klinika FN a LF UP Olomouc
3 Psychiatrická klinika FN a LF UP, Olomouc

Published: December 31, 2001  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
©arapatková H, Hrčková Y, ©moldasová J. Problematika hyperprolaktinémie při terapii sulpiridem z pohledu endokrinologa. Interní Med. 2001;3(2):80-81.

Abstrakt

V posledních letech se setkáváme s ąirokým pouľitím sulpiridu jako atypického neuroleptika nejen v psychiatrii u nemocných s psychotickými poruchami, ale také v interní medicíně v léčbě funkčních poruch gastrointestinálního traktu.

Interní a endokrinologická ordinace, Olomouc

I. interní klinika Fakultní nemocnice, Olomouc

Psychiatrická klinika Fakultní nemocnice, Olomouc

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Čeąková, E. (2000): Úskalí dlouhodobé léčby atypickými neuroleptiky. Čes. a slov. Psychiatrie 96: 6: 322-327.
    2. Hynie, S. (1999): Farmakologie v kostce. Triton: 148-150.
    3. Stárka, L. a kol. (1997): Endokrinologie. Maxdorf Jessenius, 320 pp.
    4. Stárka, L. a kol. (1999): Aktuální endokrinologie. Maxdorf Jessenius, 738 pp.
    5. ©vestka, J. (1999): Nová (atypická) antipsychotika 2. Generace. Remedia 6: 366-385.
    6. Thorner, M. et al. (1998): The Anterior Pitnitary. In: Wilson, J.D. et al.: Williams Textbook of Endocrinology. W.B. Sanders Comp.: 249 340.

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.